| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |